Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr;27(2):360-361.
doi: 10.3350/cmh.2021.0088. Epub 2021 Mar 23.

Clinical and serological prognostic markers in primary biliary cholangitis

Affiliations
Comment

Clinical and serological prognostic markers in primary biliary cholangitis

Markus Wilhelmi. Clin Mol Hepatol. 2021 Apr.
No abstract available

Keywords: Anti-gp-210 antibodies; Antibodies, Antinuclear; Cirrhosis; Primary biliary cholangitis; Prognosis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

The author has no conflicts of interest to disclose.

Comment on

References

    1. Tanaka A. Current understanding of primary biliary cholangitis. Clin Mol Hepatol. 2021;27:1–21. - PMC - PubMed
    1. Quarneti C, Muratori P, Lalanne C, Fabbri A, Menichella R, Granito A, et al. Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis. Liver Int. 2015;35:636–641. - PubMed
    1. Carbone M, Mells GF, Pells G, Dawwas MF, Newton JL, Heneghan MA, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology. 2013;144:560–569.e7. quiz e13-e14. - PubMed
    1. Huang C, Han W, Wang C, Liu Y, Chen Y, Duan Z. Early prognostic utility of gp210 antibody-positive rate in primary biliary cholangitis: a meta-analysis. Dis Markers. 2019;2019:9121207. - PMC - PubMed
    1. Granito A, Muratori P, Quarneti C, Pappas G, Cicola R, Muratori L. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn. 2012;12:65–74. - PubMed

LinkOut - more resources